University of Oulu
Also known as: Children's Hospital, Univ. of Oulu | Department of Diagnostics and Oral Medicine, Institute of Dentistry, University of Oulu, Oulu, Finland | Dept Ob-Gyn, Univeristy of Oulu | Dept Ob-Gyn, University of Oulu | Dept of Otolaryngology, University of Oulu, Finland | Dept of Pediatrics and Adolescents, Oulu University Hospital, Box 23, 90029 OYS, Finland | Dept. of Pediatrics, Oulu University Hospital | Medical Informatics and Statistics Research Group, University of Oulu | Ooulu | Oulu Central Hospital, Dept. of Obstetrics & Gynecology | Oulun yliopisto | Oulu Univerisity Hospital | Oulu University | Oulu University and Oulu University Hospital | Oulu University Central Hospital, Department of Neurology | Oulu University Hospital | Oulu University Hospital, Department of Gynecology and Obstetrics | Oulu University Hospital, Department of Internal Medicine | Oulu University Hospital, Department of Obstetrics and Gynecology | Oulu University Hospital - Dept of Internal Medicine | Oulu University Hospital, Dept of Pediatrics; PEDEGO Research unit and MRC Oulu, University of Oulu | Research Unit of Oral Health Sciences, University of Oulu, Finland | Tuula Toljamo | University hospital of Oulu | University Hospital of Oulu | University Hospital of Oulu, Finland | University Hospital of Oulu, Finland and Oregon Health Sciences University, Oregon USA | University of Oulu | University of Oulu, Deparment of Paediatrics | University of Oulu, Deparment of Peadiatric Surgery | University of Oulu, Department of dental health | University of Oulu, Department of Paediatrics | University of Oulu, Department of Paediatric Surgery | University of Oulu, Department of Pediatrics | University of Oulu. Oulu University of Applied Sciences
Highest phase reached
Phase 4
First clinical trial
Oct 1, 1994Last known activity
Sep 1, 2025
Timeline
1950s
- Jan 1, 1958
University of Oulu— Founded
Drugs by trial phase (81 distinct, 66 trials)
Phase 4 (35 own, 0 via acquisition)
Phase 3 (16 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
- Abortion, Spontaneous
- Atrial Fibrillation
- Back Pain
- Birth Weight
- Cerebral Hemorrhage
- Communicable Diseases
- Diabetes, Gestational
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Ductus Arteriosus, Patent
- Emergencies
- Fatty Liver
- Fever
- Glaucoma
- Glaucoma, Open-Angle
- Glomerulonephritis
- Hemorrhage
- Hypertension
- Hypokalemia
- IgA Vasculitis
- Infections
- Infertility
- Insulin Resistance
- Joint Diseases
- Leukemia
- Leukemia, Lymphoid
- Liver Diseases
- Low Back Pain
- Menorrhagia
- Non-alcoholic Fatty Liver Disease
- Ocular Hypertension
- Osteoarthritis, Hip
- Otitis
- Otitis Media
- Otitis Media, Suppurative
- Phimosis
- Polycystic Ovary Syndrome
- Postoperative Pain
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Pregnancy in Diabetics
- Premature Birth
- Purpura
- Recurrence
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Respiratory Tract Infections
- Seizures
- Seizures, Febrile
- Sinusitis
- Syndrome
- Thromboembolism
- Toxemia
- Urinary Tract Infections
- Venous Thromboembolism
Recent trials (50)
- NCT07155629CollaboratorPhase 3Sep 1, 2025
- NCT06523959CollaboratorPhase 4Jun 6, 2024
- NCT06282952Lead sponsorN/AApr 1, 2024
- NCT06282952CollaboratorN/AApr 1, 2024
- NCT06282952Sponsor investigatorN/AApr 1, 2024
- NCT06210269CollaboratorN/AJan 31, 2024
- NCT05444699Lead sponsorPhase 4Oct 11, 2022
- NCT05444699Reponsible party - principal investigatorPhase 4Oct 11, 2022
- NCT05337566CollaboratorN/ASep 5, 2022
- NCT05431257CollaboratorPhase 2May 24, 2022
- NCT05220280CollaboratorPhase 4Feb 6, 2022
- NCT04967118Reponsible party - principal investigatorN/AAug 30, 2021
- NCT04967118Lead sponsorN/AAug 30, 2021
- NCT04978259CollaboratorPhase 4Jul 24, 2021
- NCT04608851Overall official - principal investigatorPhase 4Dec 1, 2020
Details
- Founded
- Oulu, FI Jan 1, 1958
- Last known activity
- Sep 1, 2025